Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-022988)

Filing Details

Accession Number:: 0001209191-22-022988
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-04-05 16:15:29
Reporting Period:: 2022-04-01

Accepted Time:: 2022-04-05 16:15:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1748907	Orchard Therapeutics Plc	ORTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1793992	Bobby Gaspar	C/O Orchard Therapeutics Plc 108 Cannon Street London X0 EC4N 6EU	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2022-04-01	15,000	$0.74	366,158	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	2,000	Indirect	By Reporting Person's Child
Ordinary Shares	2,000	Indirect	By Reporting Person's Child

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.722 to $0.75. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.